ArticleCureus2024

Long-Term Success With a TDM-1 Biosimilar in Recurrent HER2-Positive Breast Cancer With Multisite Metastases: A Comprehensive Case Study.

Ghanashyam Biswas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.